Determination of lipid profiles and use of statins in patients with ischemic stroke or transient ischemic attack.

BACKGROUND AND PURPOSE: Statins reduce the risk of myocardial infarction and stroke in patients with vascular disease. Inappropriate serum lipid determination and underuse of statins have been documented in patients with coronary artery disease. Evaluation of hyperlipidemia and treatment with statins in patients with recent ischemic cerebrovascular events have not yet been investigated. METHODS: We [...]

Determination of lipid profiles and use of statins in patients with ischemic stroke or transient ischemic attack.2024-03-21T12:42:58+01:00

Proteomic evaluation of intermediary metabolism enzyme proteins in fetal Down’s syndrome cerebral cortex.

Trisomy 21 (Down's syndrome) is the most common genetic cause of human mental retardation. In Down's syndrome (DS) patients, deteriorated glucose, lipid, purine, folate and methionine/homocysteine metabolism has been reported. In our study, we used a proteomic approach to evaluate protein expression of enzyme proteins of intermediary metabolism in the brain of Down's syndrome fetuses. [...]

Proteomic evaluation of intermediary metabolism enzyme proteins in fetal Down’s syndrome cerebral cortex.2024-03-21T12:42:58+01:00

Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry.

BACKGROUND AND PURPOSE: Oral anticoagulation (OAC) and antiplatelet drugs are effective in the secondary prevention of ischemic cerebrovascular events. Only few data exist about the factors influencing the choice of a specific therapy for secondary prevention in patients with a recent stroke or transient ischemic attack (TIA). METHODS: Within a cross-sectional study, nested in a [...]

Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry.2024-03-21T12:42:58+01:00